Closing prices for 09 October 2026
Next earnings report: 29 October 2026 · Earnings calendar
The series is stated in the current share scale after splits; dividends are not included in the price
argenx SE trades on Nasdaq under the ticker ARGX. The company belongs to the Health care sector. The trading history on this page starts on 18 May 2017.
Over the past 52 weeks ARGX has traded between 661.85 $ and 1,073 $. As of 09 October 2026 the price stood 39.71 % of the way from the 52-week low to the high.
Over one year ARGX shares rose 3.27 %; over six months they rose 3.17 %. Volatility over 90 days is 47.66 %. Dividends are not included: this is price change only, as of 09 October 2026.
argenx SE reported revenue of 4.2B $ and net income of 1.3B $ for the latest fiscal year. Net margin is 31.12 %. Revenue changed by +89.91 % year over year. Earnings per share are 19.57 $.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 09 October 2026 | 821.96 | 826.78 | 805.07 | 825.03 | 512,200 |
| 08 October 2026 | 831.23 | 832.24 | 787.73 | 818.63 | 2M |
| 07 October 2026 | 932.08 | 942.69 | 921.72 | 928.44 | 258,300 |
| 06 October 2026 | 922.39 | 942.35 |
Based on the fiscal year ended 31 December 2025
The sector median covers every company in the sector on the US market, loss-making ones included.
Share count is a period average, so market cap is approximate.
argenx SE (ARGX) is a public company in the healthcare sector. Its depositary receipts trade on NASDAQ.
Over the trailing twelve months as reported to 2025-12-31, revenue was 4.2bn $, net income was 1.3bn $. Incorporated in NL.
This summary is compiled automatically from SEC filings and exchange data.
Address:INDUSTRIEPARK ZWIJNAARDE 7 BUILDING C B-9052, ZWIJNAARDE
ARGX has a return on equity of 17.64 %, above the sector median of −41.68 %. Return on assets is 14.88 %, above the sector median of −32.11 %. Operating margin is 25.38 %, above the sector median of −26.84 %.
| 4M |
| MESOMesoblast Limited | 14.29 | +3.93 % | 3M |
| AUTLAutolus Therapeutics plc | 1.81 | +2.26 % | 3M |
| CLLSCellectis S.A. | 1.26 | +0.80 % | 251,906 |
| VALNValneva SE | 5.78 | +1.58 % | 190,558 |
| 909.95 |
| 930.52 |
| 430,100 |
| 05 October 2026 | 920.83 | 923.31 | 903.50 | 912.87 | 322,100 |
| 02 October 2026 | 926.86 | 928.96 | 912.96 | 919.21 | 333,900 |
| 01 October 2026 | 957.22 | 972.38 | 935.24 | 936.00 | 302,200 |
| 30 September 2026 | 970.08 | 970.27 | 952.27 | 958.91 | 243,700 |
| 29 September 2026 | 965.05 | 974.25 | 956.25 | 970.66 | 311,000 |
| 28 September 2026 | 954.76 | 977.01 | 954.76 | 972.25 | 264,700 |
| 25 September 2026 | 965.23 | 967.71 | 956.24 | 959.49 | 264,400 |
| 24 September 2026 | 945.81 | 965.34 | 944.21 | 962.22 | 323,700 |
| 23 September 2026 | 974.60 | 974.60 | 934.19 | 945.82 | 426,500 |
| 22 September 2026 | 986.43 | 986.77 | 963.50 | 963.79 | 304,400 |
| 21 September 2026 | 996.50 | 1,002 | 986.56 | 988.20 | 231,600 |
| 18 September 2026 | 1,002 | 1,004 | 989.33 | 990.32 | 244,000 |
| 17 September 2026 | 991.74 | 1,001 | 988.57 | 995.77 | 245,900 |
| 16 September 2026 | 981.94 | 988.34 | 974.26 | 984.69 | 200,600 |
| 15 September 2026 | 985.87 | 1,001 | 977.03 | 979.76 | 235,300 |
| 14 September 2026 | 1,005 | 1,008 | 988.40 | 990.54 | 198,600 |